Drug Formulation Challenge 4

Injectable Formulation Developed for a Low Solubility Compound at a High Dose


Our client had a poorly soluble, non-ionizable compound and required a high dose injectable formulation for animal studies.

Velesco solution:

  • Regular solvent mixtures were unable to achieve the required dose, but the precipitation characteristics suggested nucleation inhibitors might work.
  • A successful non-toxic drug formulation containing anti-nucleation polymers was developed.

Back to drug formulation development case studies

News and Events

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.


CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing


2 new job postings! Careers 


Velesco's work published 

 Outsourcing Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.


Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100